A robot named Abi, tested in a senior care home in Melbourne, Australia in 2025, is now making its way to senior care facilities in the United States, according to reporting from The Washington Post on April 9, 2026. Abi is part of a growing category of AI-powered robot companions built specifically to address one of the most stubborn problems in elder care: chronic loneliness among older adults living in institutional settings.
What Abi actually does
Abi combines several functions that are normally spread across separate devices or human staff: it offers daily reminders, detects falls, prompts residents about medications, and engages in what developers describe as empathetic dialogue — conversation designed to feel responsive and warm rather than transactional. The pitch isn’t that Abi replaces a single task a nurse might do, but that it provides a persistent, always-available presence that can notice problems and offer companionship between the moments when human staff are physically present.
Abi isn’t alone in this market
The Post’s coverage situates Abi within a wider field of humanoid and companion robots aimed at similar problems, naming several other models now competing for a role in senior care: Ameca, NEO Home Robot, Walker X, GR-3, and Panther. That crowded field suggests investors and developers see real demand building, driven by aging populations in wealthy countries and persistent staffing shortages in long-term care.
The acceptance numbers
Studies cited in the coverage report acceptance rates of 70% to 80% among seniors who were tested with companion robots — a notably high figure for a technology that, on paper, sounds like it could feel cold or intrusive to an older population. That level of acceptance is one reason developers argue these robots deserve serious consideration as a care tool rather than a novelty, though acceptance in a study setting doesn’t necessarily predict sustained use once the novelty of a new device wears off.
A different model for institutional settings: Moya
Not every robot in this space is aimed at private homes. Moya, a separate robot mentioned in the reporting, targets care facilities and hospitals rather than individual seniors’ homes, and it carries an institutional price tag to match: roughly $173,000 per unit. A first batch of around 50 Moya units is expected to ship in late 2026, giving the sector one of its first real tests of whether facilities are willing to make that scale of capital investment in robotic care support.
The pushback: cost, data, and what gets displaced
Critics raise three distinct concerns. First is simple cost — a $173,000 unit price for Moya puts serious robotic companions well out of reach for many smaller or under-resourced facilities, raising the risk that only well-funded institutions can offer residents this kind of support. Second is data: companion robots that hold empathetic conversations and monitor falls and medication are, by design, collecting continuous personal and health information about vulnerable seniors, raising questions about who owns that data, how it’s secured, and how it might be used beyond direct care. Third, and most fundamental, is the worry that robots marketed to combat loneliness could end up substituting for genuine human contact rather than supplementing it — that facilities under budget pressure might reduce human staffing time on the assumption that a robot companion fills the gap, when what residents actually need is more human connection, not a technological stand-in for it.
What’s next
Abi’s move from a single Melbourne pilot to US facilities will be an early test of whether the acceptance rates seen in controlled studies translate into sustained, real-world use. Moya’s late-2026 shipment of roughly 50 units will offer a parallel test case for the institutional end of the market. Expect regulators, care advocates, and families to press hard on the data-privacy and staffing-displacement questions well before this becomes a settled part of standard elder care, even as the underlying loneliness problem these robots are meant to address remains urgent and, so far, only partially solved. How US facilities structure consent, data retention, and staffing policy around these devices in their first deployments will likely shape the regulatory conversation for the entire category going forward, since the United States currently has no dedicated federal framework governing companion robots used in senior care settings.
